Subsequently, we evaluated the impact of SDC3 expression on the prognosis of ovarian cancer patients overall, by quartile expression, and subjected to chemotherapy, using the public online resource KM plotter, which combines public gene expression data based on Affymetrix gene array analyses of 1435 ovarian cancer patients in the GEO and TCGA datasets [27] and using and the CSIOVDB platform which provides integration with the copy number, DNA methylation, and mutation data from TCGA [28]. Here, SDC3 is linked to ovarian carcinoma.